Annual Drug Patent Expirations for RESCULA
Rescula is a drug marketed by Sucampo Pharma Llc and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.
This drug has twenty-one patent family members in eighteen countries.
The generic ingredient in RESCULA is unoprostone isopropyl. Additional details are available on the unoprostone isopropyl profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
